Clinical trials save lives.
Research is where the answers
lie.
Without research, there are
no clinical trials.
Without clinical trials,
people do and will continue to die.
Without people, trials can
not take place.
So the real question is this.
Have you stepped up?
Too many people equate participation
in clinical trials with being a lab rat. Let's take a moment to dispel some
myths or clarify some facts. First the basics.
The very first basic simple
truth: Navigating clinicaltrials.gov can be extremely frustrating, even to the
most seasoned doctors. Since the very first step is knowing where to look for
these things, there are platforms out there to help make the process easier. Social media is changing the way researchers and participants connect. We should be doing this faster, better and more efficiently.
Now some background and general facts.
Now some background and general facts.
Clinical trails must adhere
to the highest standards to protect trial participants. There are laws in place to
ensure the risk associated with any research is no greater than the normal risks inherent in every day living.
When you make a choice to
participate in a clinical trial, first and foremost, you will always receive the best evidence-based
medical care currently approved and being used to treat the condition or
disease being studied.
With those two things in
mind, yes, there are risks associated with clinical trials but any new
medication that is granted approval to proceed to human testing has already
undergone rigorous studies in a petrie dish, on a lab slide and generally, in
animal studies. Only after the safety has been established throughout that
process, can a drug proceed to trials using real people. Human clinical trials
run in phases, too. For this conversation, let’s focus on the last leg of the
human trials, the Phase III trial.
By the time a drug is
approved for phase III trials, the researchers have already determined its
safety, identified most of the short term side effects and it’s already shown
the new drug or drug combination may be more beneficial than the current
standard of care. And that’s the biggest and most important reason to consider
joining a trial for which you may be eligible.
I wish that I had paid more
attention to this when I was diagnosed with invasive breast cancer. I know
there are trials I would have sought to join. The thing is, the guidelines are
set in stone and if you choose a treatment before knowing all of the available
options, you can’t unring the bell. You may have excluded yourself from being among
the first to gain access to a drug that could take years to become available to
the rest of us. The process from trial to results to publication to approval is
long.
Like it? Share it!
No comments:
Post a Comment
Something to add? Do Share!